196 related articles for article (PubMed ID: 26292315)
21. Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, central Africans, and Amerindians.
Cimarelli A; Duclos CA; Gessain A; Cattaneo E; Casoli C; Biglione M; Mauclère P; Bertazzoni U
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):198-204. PubMed ID: 7552486
[TBL] [Abstract][Full Text] [Related]
22. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data.
Kwaan N; Lee TH; Chafets DM; Nass C; Newman B; Smith J; Garratty G; Murphy EL;
J Infect Dis; 2006 Dec; 194(11):1557-64. PubMed ID: 17083040
[TBL] [Abstract][Full Text] [Related]
23. Telomere Length, Proviral Load and Neurologic Impairment in HTLV-1 and HTLV-2-Infected Subjects.
Usadi B; Bruhn R; Lin J; Lee TH; Blackburn E; Murphy EL
Viruses; 2016 Aug; 8(8):. PubMed ID: 27529270
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.
Dehée A; Césaire R; Désiré N; Lézin A; Bourdonné O; Béra O; Plumelle Y; Smadja D; Nicolas JC
J Virol Methods; 2002 Apr; 102(1-2):37-51. PubMed ID: 11879691
[TBL] [Abstract][Full Text] [Related]
25. Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR.
Rodrigues ES; Salustiano S; Santos EV; Slavov SN; Picanço-Castro V; Maçonetto JM; de Haes TM; Takayanagui OM; Covas DT; Kashima S
J Neurovirol; 2022 Feb; 28(1):27-34. PubMed ID: 35025066
[TBL] [Abstract][Full Text] [Related]
26. Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results.
Vitone F; Gibellini D; Schiavone P; D'Antuono A; Gianni L; Bon I; Re MC
BMC Infect Dis; 2006 Mar; 6():41. PubMed ID: 16512894
[TBL] [Abstract][Full Text] [Related]
27. [HTLV-1 and HTLV-2 proviral load: a simple method using quantitative real-time PCR].
Tamegão-Lopes BP; Rezende PR; Maradei-Pereira LM; de Lemos JA
Rev Soc Bras Med Trop; 2006; 39(6):548-52. PubMed ID: 17308700
[TBL] [Abstract][Full Text] [Related]
28. Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases.
Demontis MA; Hilburn S; Taylor GP
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):359-64. PubMed ID: 22894552
[TBL] [Abstract][Full Text] [Related]
29. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
Lezin A; Olindo S; Oliere S; Varrin-Doyer M; Marlin R; Cabre P; Smadja D; Cesaire R
J Infect Dis; 2005 Jun; 191(11):1830-4. PubMed ID: 15871115
[TBL] [Abstract][Full Text] [Related]
30. Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes.
Ueno S; Umeki K; Takajo I; Nagatomo Y; Kusumoto N; Umekita K; Morishita K; Okayama A
Int J Cancer; 2012 May; 130(10):2318-26. PubMed ID: 21780105
[TBL] [Abstract][Full Text] [Related]
31. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study.
Kira J; Koyanagi Y; Yamada T; Itoyama Y; Goto I; Yamamoto N; Sasaki H; Sakaki Y
Ann Neurol; 1991 Feb; 29(2):194-201. PubMed ID: 2012389
[TBL] [Abstract][Full Text] [Related]
32. Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers.
Medina F; Quintremil S; Alberti C; Godoy F; Pando ME; Bustamante A; Barriga A; Cartier L; Puente J; Tanaka Y; Valenzuela MA; Ramírez E
J Med Virol; 2016 Mar; 88(3):521-31. PubMed ID: 26241614
[TBL] [Abstract][Full Text] [Related]
33. Evolution of HTLV-1 proviral load in patients from Salvador, Brazil.
Olavarria VN; Gomes Ado N; Kruschewsky Rde A; Galvão-Castro B; Grassi MF
Braz J Infect Dis; 2012; 16(4):357-60. PubMed ID: 22846124
[TBL] [Abstract][Full Text] [Related]
34. Proviral load determination of HTLV-1 and HTLV-2 in patients' peripheral blood mononuclear cells by real-time PCR.
Casoli C; Pilotti E; Bertazzoni U
Methods Mol Biol; 2014; 1087():315-23. PubMed ID: 24158833
[TBL] [Abstract][Full Text] [Related]
35. Real-time polymerase chain reaction for quantification of HTLV-1 proviral load: application for analyzing aberrant integration of the proviral DNA in adult T-cell leukemia.
Kamihira S; Dateki N; Sugahara K; Yamada Y; Tomonaga M; Maeda T; Tahara M
Int J Hematol; 2000 Jul; 72(1):79-84. PubMed ID: 10979214
[TBL] [Abstract][Full Text] [Related]
36. Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction.
Albrecht B; Collins ND; Newbound GC; Ratner L; Lairmore MD
J Virol Methods; 1998 Nov; 75(2):123-40. PubMed ID: 9870588
[TBL] [Abstract][Full Text] [Related]
37. Quantification of proviral DNA load in human T-cell leukaemia virus type I infections.
Tosswill JH; Taylor GP; Clewley JP; Weber JN
J Virol Methods; 1998 Nov; 75(1):21-6. PubMed ID: 9820571
[TBL] [Abstract][Full Text] [Related]
38. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
39. The genetic background as a determinant of human T-cell leukemia virus type 1 proviral load.
Nitta T; Tanaka M; Sun B; Hanai S; Miwa M
Biochem Biophys Res Commun; 2003 Sep; 309(1):161-5. PubMed ID: 12943677
[TBL] [Abstract][Full Text] [Related]
40. High simian T-cell leukemia virus type 1 proviral loads combined with genetic stability as a result of cell-associated provirus replication in naturally infected, asymptomatic monkeys.
Gabet AS; Gessain A; Wattel E
Int J Cancer; 2003 Oct; 107(1):74-83. PubMed ID: 12925959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
